Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alvin T. Lo
HER2 Signaling Pathway Activation and Response of Breast Cancer Cells to HER2-targeting Agents Is Dependent Strongly on the 3D Microenvironment
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
Crosstalk Between Oxidative Stress Signaling and HER2 Pathway in Breast Cancer
American Journal of Immunology
Allergy
Immunology
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
Overcoming Resistance Against HER2-Targeting Agents in Fifth-Line Therapy: Is There Still a Place for Bevacizumab in HER2+ Breast Cancer?
Clinical Breast Cancer
Cancer Research
Oncology
Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis
Oncoscience
Cancer Research
Oncology
HER2 Expression in NF1 Breast Cancer—Response
Cancer Prevention Research
Medicine
Cancer Research
Oncology
EGFR and HER2 Signaling in Breast Cancer Brain Metastasis
Frontiers in Bioscience - Elite
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
Scientific Reports
Multidisciplinary
Efficacy and Safety of HER2-Targeted Agents for Breast Cancer With HER2-Overexpression: A Network Meta-Analysis
PLoS ONE
Multidisciplinary